Skip to main navigation
Tenaya Therapeutics
  • Careers at Tenaya
  • Contact Us
  • Leadership
  • Our Science
    • Platforms
    • Capabilities
    • Collaborations
    • Publications & Presentations
  • Our Programs
    • Pipeline
    • Programs
  • Patients & Families
    • Overview
    • Tenaya Approach
    • Advocacy Partners
    • Studies
    • Our Inspiration
    • Resources
  • Investors
    • News & Events
      • Press Releases
      • In the News
      • Events & Presentations
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quote & Chart
    • IR Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts

Investor Portal

May 11, 2022
Tenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
May 03, 2022
Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting
Apr 28, 2022
Tenaya Therapeutics to Present Preclinical Data on TN-401 PKP2 Gene Therapy Program at Heart Rhythm 2022
Mar 24, 2022
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
Mar 23, 2022
Tenaya Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Updates
Jan 31, 2022
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
Jan 10, 2022
Tenaya Therapeutics Provides 2022 Business Updates
RSS Feeds
Email Alerts
Contact IR
Print

Privacy Policy | Terms of Use    © 2022 Tenaya Therapeutics. All rights reserved.